Quality Investor
About 

Dillards Capital Trust I CAP SECS 7.5%

Rank #33Value

DDT · NYSE

Dillards Capital Trust I CAP SECS 7.5% (DDT) — Rank #33 by gross profitability (GP/assets 0.68) · ROE 26.9% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0000028917 · all metrics point-in-time as of the filing date.

About

State
TX
Filer Category
Large accelerated filer
Fiscal Year End
January 30

Price History

DDT+41.4% · +7.2% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and dividend yield are the primary valuation lenses for mature businesses.

Market Cap

—

P/E (annual)

0.7

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

—

Industry

—

Exchange

NYSE

Signal Flags

2 green1 red
Revenue growth acceleratingGrowth rate increasing year over year
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Revenue declining YoYRevenue contracted year over year

Quality Profile

Profitability

1/1 pass
GP / assets
0.68
Return on equity
26.9%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.77
Current ratio
3.03×
Net cash
$763.08M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
—

Growth

1/2 pass
Revenue growth
-0.4%
Piotroski F-Score
N/A
Share dilution
-2.9%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

3 of 5 thresholds not computable from filed data.

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

0.7xFair
0.5xmed 0.7x5.1x

P / S

Price / revenue per share

0.0xCheap
0.0xmed 0.1x0.1x

P / B

Price / book value per share

0.0xCheap
0.0xmed 0.3x0.5x

P / GP

Price / gross profit per share

0.0xCheap
0.0xmed 0.2x0.5x

P / FCF

Price / free cash flow per share

0.0xCheap
0.0xmed 1.2x5.3x

Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).

Profitability

Gross profitability (GP / assets)

0.68

Primary signal (Novy-Marx).

1st of 6 SIC 53 peers

Return on equity

26.9%

Gross margin

39.0%

2nd of 6 SIC 53 peers

Revenue growth (YoY)

-0.4%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2023202420252026
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

-2.1%

Revenue CAGR (5Y)

8.2%

Earnings CAGR (3Y)

-13.8%

FCF CAGR (3Y)

-9.0%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.77

2nd of 6 SIC 53 peers (best = lowest)

Current ratio

3.03×

1st of 6 SIC 53 peers

Quick ratio

0.91×

Net cash

$763.08M

Cash & equivalents minus total debt.

Recession resistance

Revenue through recessions

Worst single-year YoY revenue decline, 18 years of history

Moderate
2008-2009 (GFC)
N/AN/A
2020 (COVID)
-2.5%Mild decline
Worst year on record(any fiscal year, not recession-limited)
-30.1%Significant decline

Cash-flow health

Free cash flow

$623.63M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

0.09

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

—

Stock-based comp intensity.

Dividend safety

Composite score

1.8 / 5

Weak
Payout ratio
85.0%1/5 Weak
FCF coverage
1.29×2/5 Fair
Dividend growth streak
3 yr2/5 Fair
Balance-sheet health
D/E 0.77 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20212026
Decline
Hypergrowth
Capital Return
Value
View full financial statements →